BMT Tandem "Scientific" Meeting
Ballroom E-H (Salt Palace Convention Center)
Chairs:
Alan M. Hanash, MD, PhD
and
Sophie Paczesny
Summary:
Abstracts: #2186, 2241, 2401, 2600, 2058, 2662
Fetal Membrane Cells for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Olle Ringden, MD, PhD, Karolinska. Institutet;
Tom Erkers, MSc, Karolinska Institutet;
Silvia Nava, BSc, Karolinska Institutet;
Mehmet Uzunel, MD, PhD, Karolinska University Hospital;
Erik Iwarsson, MD, Karolinska Institutet;
Réka Conrad, PhD, Karolinska Institutet;
Magnus Westgren, MD, PhD, Karolinska Institutet;
Jonas Mattsson, MD PhD, Karolinska University Hospital;
Helen Kaipe, PhD, Karolinska Institutet
α-Mannan Can Induce Acute Pulmonary Gvhd Dependent On Th17 Subsets
Hidetaka Uryu, Kyushu University Graduate School of Medical Science;
Hideyo Oka, Kyushu University Graduate School of Medical Science;
Sonoko Shimoji, Kyushu University Graduate School of Medical Science;
Yoshihiro Eriguchi, Kyushu University Graduate School of Medical Science;
Shuichiro Takashima, Kyushu University Graduate School of Medical Science;
Koji Kato, Kyushu University Graduate School of Medical Science;
Koichi Akashi, Kyushu University Graduate School of Medical Science;
Takanori Teshima, Hokkaido University Graduate School of Medicine
Plasma ST2 Concentrations Predict Acute Gvhd Development and Non-Relapse Mortality
Mark Vander Lugt, MD, University of Michigan;
Thomas Braun, Ph.D., University of Michigan;
Samir Hanash, MD, PhD, Fred Hutchinson Cancer Research Center;
James L.M. Ferrara, M.D., D.Sc., University of Michigan;
Jerome Ritz, MD, Dana-Farber Cancer Institute;
Vincent T. Ho, MD, Dana-Farber Cancer Institute;
Joseph H Antin, MD, Dana-Farber Cancer Institute;
Qing Zhang, Fred Hutchinson Cancer Research Center;
Alice Chin, Fred Hutchinson Cancer Research Center;
Aurelie Gomez, MD, University of Michigan;
Andrew C. Harris, M.D., University of Michigan;
John E Levine, M.D., M.S., University of Michigan;
Sung Won Choi, M.D., University of Michigan;
Daniel R. Couriel, M.D., University of Michigan;
Pavan Reddy, M.D., University of Michigan;
Sophie Paczesny, M.D., Ph.D., University of Michigan
Interim Analysis of a Phase II Trial of Montelukast for the Treatment of Bronchiolitis Obliterans Syndrome After HSCT Reveals Immunobiology of Disease
Kirsten M Williams, MD, Children's National Medical Center;
Steven Z. Pavletic, MD, National Institute of Health NIH;
Stephanie J. Lee, MD, MPH, Fred Hutchinson Cancer Research Center;
Candice Cottle-Delisle, RN, ETIB/NCI/NIH;
Fran Hakim, PhD, National Cancer Institute, Nih;
Beryl Manning-Geiss, NCI/NIH;
Sandra Mitchell, PhD, CRNP, National Institutes of Health;
Juan Gea-Banacloche, MD, National Institute of Health NIH;
Leora Comis, NIH;
Edward W Cowen, MD, NIH;
Kristin Baird, MD, National Institute of Health NIH;
James H Shelhamer, MD, CCMD NIH;
Daniel Fowler, MD, National Institute of Health;
Bazetta AJ Blacklock-Schuver, RN, ETIB/NCI/NIH;
Daniele Avila, MSN, NCI;
Ronald Gress, MD, National Cancer Institute
Lower Uric Acid Level At the Time of Allogeneic Hematopoietic Cell Transplantation (HCT) Is Protective Against Acute Graft-Vs-Host-Disease
Albert C Yeh, BA, Harvard Medical School;
Andrew M. Brunner, MD, Massachusetts General Hospital;
Thomas R. Spitzer, MD, Massachusetts General Hospital;
Yi-Bin Chen, MD, Massachusetts General Hospital;
Erin Coughlin, Massachusetts General Hospital;
Steven L. McAfee, MD, Massachusetts General Hospital;
Karen Ballen, MD, Massachusetts General Hospital;
Eyal C. Attar, MD, Massachusetts General Hospital;
Martin L Caron, Massachusetts General Hospital;
Frederick Preffer, PhD, Massachusetts General Hospital;
Beow Yeap, ScD, Massachusetts General Hospital;
Bimalangshu R Dey, MD, PhD, Massachusetts General Hospital
Treatment of Steroid Resistant Grade II to IV Acute Gvhd by Infusion of Mesenchymal Stroma Cells Expanded with Platelet Lysate - a Phase I/II Study
Liane te Boome, MD, UMC Utrecht;
Cristina Mansilla, BsC, PhD, Biomedical Research Center of Navarra;
Caroline Lindemans, MD, PhD, UMC Utrecht, Wilhelmina Children's Hospital;
Lotte van der Wagen, MD, UMC Utrecht;
Marloes Cuijpers, MD, UMC Utrecht;
Ineke Slaper-Cortenbach, PhD, UMC Utrecht;
Henk Rozemuller, PhD, UMC Utrecht;
Eefke Petersen, MD, PhD, UMC Utrecht;
Eric Spierings, PhD, UMC Utrecht;
Marc Bierings, MD, University Children's Hospital;
Jaap-Jan Boelens, MD, PhD, Wilhelmina Children's Hospital/UMCU;
Nico Wullfraat, MD, PhD, UMC Utrecht;
Jurgen Kuball, Associate Professor, UMC Utrecht